Helicobacter pylori infection is an infectious disease and the empiric therapy paradigm should be changed. Issue 2 (19th June 2019)

• Record Type: Journal Article
• Authors: Li, Hong; Yang, Tiankuo; Tang, Hong; Tang, Xiaoqiong; Shen, Yalin; Benghezal, Mohammed; Tay, Alfred; Marshall, Barry
• Is Part Of: Precision clinical medicine. Volume 2:Issue 2(2019)
• Page Start: 77
• Page End: 80
• Publication Date: 2019-06-19
• Subjects: Helicobacter pylori -- antimicrobial susceptibility testing -- infectious disease; Medicine -- Periodicals; Medical care -- Periodicals; Personalized medicine -- Periodicals; 610
• DOI: 10.1093/pcmedi/pbz009
• Languages: English
• ISSNs: 2096-5303

Abstract

Abstract: Helicobacter pylori infection is an infectious disease. Given the alarmingly high antibiotic resistance in H. pylori, gastroenterologists should change the empiric H. pylori treatment paradigm to an antimicrobial susceptibility testing-guided precision treatment. Antimicrobial stewardship programs for H. pylori should be implemented locally, regionally, and nationally to monitor the antibiotic resistance pattern.